Travere Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Travere Therapeutics shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Travere Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Travere Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Travere Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $63k | 50k | 1.26 |
| 2024-03-31 | $13M | 20M | 0.63 |
| 2023-12-31 | $13M | 20M | 0.66 |
| 2023-09-30 | $13M | 20M | 0.64 |
| 2023-03-31 | $15M | 15M | 0.98 |
| 2022-12-31 | $14M | 15M | 0.91 |
| 2022-09-30 | $15M | 15M | 1.02 |